Prognostic value of atrial strain measured by CMR in hypertrophic cardiomyopathy

View at publisher
Authors: Maria Soledad Ceballos, Guillem Casas, Francisco Gonzalez‐Santorum, Arnau Subirà Ingla, Giulia Ricci, F S Cabrera, Andrea Faggiano, Leandro Santiago Videla, P Escribano Escribano, Filipa Xavier Valente, Ruper Oliveró, Gisela Teixidó‐Turà
+3 more Javier Limeres Freire, Ignacio Ferreira, J F Rodriguez Palomares
Cited by: 0

Abstract

Abstract Introduction and Objectives Hypertrophic cardiomyopathy (HCM) increases the risk of major adverse cardiovascular events (MACE). However, current predictive models are imperfect. Left atrial global longitudinal strain (LA-GLS), assessed by cardiac magnetic resonance (CMR), may enhance cardiovascular risk stratification. This study aimed to evaluate the prognostic value of CMR-derived LA-GLS in predicting MACE in a cohort of patients with HCM. Methods This was a retrospective, longitudinal, single-center study including 282 patients with HCM who underwent CMR. LA-GLS was assessed using feature-tracking. The primary endpoint (MACE) was a composite of ventricular arrhythmias (including sudden cardiac death, sustained and non-sustained ventricular tachycardia, and appropriate ICD discharge), heart failure (hospitalization, transplant, or ventricular assist device), and cardiovascular mortality. Results The mean age was 56.8 ± 17.3 years, and 42.9% were women. The maximum wall thickness (MWT) was 17.3 ± 4.3 mm, late gadolinium enhancement (LGE) was present in 140 patients (51.1%), and LA-GLS was 27.4 ± 14.4%. Genetic testing was positive in 96 patients (49.2%). During a median follow-up of 6.5 years (interquartile range: 3.4–8.5 years), 71 patients (25%) experienced MACE, including 4 sudden cardiac deaths, 12 poorly tolerated sustained ventricular tachycardias, 6 ICD discharges, 26 hospitalizations for heart failure, 2 transplants, 1 ventricular assist device, and 8 cardiovascular deaths. Table 1 shows the CMR variables according to the occurrence of MACE. In multivariate analysis, adjusted for MWT, indexed myocardial mass, and indexed left ventricular end-systolic volume, the variables independently associated with MACE were LVEF (HR 0.95, 95% CI 0.91–0.99, p = 0.046), LA-GLS below the median value (27.8%) (HR 1.83, 95% CI 1.07–3.14, p = 0.028; Figure 1A), and LGE >5% of total myocardial mass (HR 2.82, 95% CI 1.59–5.03, p < 0.001). This model demonstrated good predictive value, with an area under the curve of 0.72 (95% CI 0.65–0.79) (Figure 1B). Conclusions Atrial strain measured by CMR is associated with increased risk of cardiovascular events in HCM beyond established prognostic variables. Our CMR-based predictive model showed good discriminant value. Integrating atrial strain assessment into clinical practice may optimize patient management.

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Cardiovascular Function and Risk Factors Cardiovascular Effects of Exercise

Publication details

Journal / source
European Heart Journal - Cardiovascular Imaging
Volume
27
Issue
Supplement_1
Publication date
1 January 2026
Language
EN